Collegeville, PA, United States of America

Angel I Morales-Ramos

This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angel I Morales-Ramos. Retrieved from https://idiyas.com/inventor/angel-i-morales-ramos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angel I Morales-Ramos: Innovator in Interferon Gene Modulation

Introduction

Angel I Morales-Ramos is a notable inventor based in Collegeville, PA (US). She has made significant contributions to the field of biotechnology, particularly in the modulation of stimulator of interferon genes (STING). Her work has implications for therapeutic advancements in various diseases.

Latest Patents

Angel I Morales-Ramos holds a patent for "Modulators of stimulator of interferon genes (STING)." The patent discloses compounds having a specific formula, wherein various components are defined, including potential tautomers and pharmaceutically acceptable salts. This innovation represents a step forward in the development of treatments targeting STING pathways.

Career Highlights

Throughout her career, Morales-Ramos has been associated with GlaxoSmithKline Intellectual Property Development Limited. Her role in this organization has allowed her to focus on groundbreaking research and development in the pharmaceutical sector.

Collaborations

Some of her notable coworkers include David T Fosbenner and Todd L Graybill. Their collaborative efforts contribute to the innovative environment at GlaxoSmithKline.

Conclusion

Angel I Morales-Ramos exemplifies the spirit of innovation in biotechnology through her patent work and collaborations. Her contributions to the modulation of STING genes are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…